Literature DB >> 29926151

[Treatment of chylothorax].

M Schirren1, S Sponholz1, J Schirren2.   

Abstract

Chylothorax is an infrequent but important form of pleural effusion. The most common causes are of postoperative and neoplastic origin. No prospective or randomized trials have been performed to evaluate the available treatment options for chylothorax. The basic principles of conservative treatment include drainage of the effusion and dietary measures. Chylothorax is typically treated conservatively. In the case of failure of conservative treatment, interventional radiological or surgical procedures are applied. Untreated chylothorax has a high morbidity and mortality.

Entities:  

Keywords:  Chylous effusion; Differential diagnosis; Duct ligation; Surgery complications; Thoracic duct

Mesh:

Year:  2018        PMID: 29926151     DOI: 10.1007/s00104-018-0659-5

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  25 in total

1.  A morphological study of the thoracic duct at the jugulo-subclavian junction.

Authors:  R J Langford; A T Daudia; T J Malins
Journal:  J Craniomaxillofac Surg       Date:  1999-04       Impact factor: 2.078

Review 2.  Does ligation of the thoracic duct during oesophagectomy reduce the incidence of post-operative chylothorax?

Authors:  Clarisa T P Choh; Omar A Khan; Igor J Rychlik; Kieran McManus
Journal:  Int J Surg       Date:  2012-03-21       Impact factor: 6.071

3.  Postesophagectomy chylothorax: incidence, risk factors, and outcomes.

Authors:  Rachit D Shah; James D Luketich; Matthew J Schuchert; Neil A Christie; Arjun Pennathur; Rodney J Landreneau; Katie S Nason
Journal:  Ann Thorac Surg       Date:  2012-01-15       Impact factor: 4.330

4.  Chylothorax causing reversible T-cell depletion.

Authors:  J R Breaux; C Marks
Journal:  J Trauma       Date:  1988-05

Review 5.  Chylothorax and cholesterol pleural effusion.

Authors:  J Terrill Huggins
Journal:  Semin Respir Crit Care Med       Date:  2011-01-06       Impact factor: 3.119

6.  Postoperative chylothorax.

Authors:  R J Cerfolio; M S Allen; C Deschamps; V F Trastek; P C Pairolero
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

7.  A simple method minimizes chylothorax after minimally invasive esophagectomy.

Authors:  Yaxing Shen; Mingxiang Feng; Muhammad Asim Khan; Hao Wang; Lijie Tan; Qun Wang
Journal:  J Am Coll Surg       Date:  2013-11-07       Impact factor: 6.113

8.  The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection.

Authors:  Ayesha S Bryant; Douglas J Minnich; Benjamin Wei; Robert James Cerfolio
Journal:  Ann Thorac Surg       Date:  2014-05-06       Impact factor: 4.330

9.  Incidence and management of chylothorax after Ivor Lewis esophagectomy for cancer of the esophagus.

Authors:  Sebastian Brinkmann; Wolfgang Schroeder; Kristina Junggeburth; Christian A Gutschow; Marc Bludau; Arnulf H Hoelscher; Jessica M Leers
Journal:  J Thorac Cardiovasc Surg       Date:  2016-01-22       Impact factor: 5.209

10.  Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series.

Authors:  D C Mares; P N Mathur
Journal:  Chest       Date:  1998-09       Impact factor: 9.410

View more
  2 in total

Review 1.  [The technique of thoracic lymph node dissection].

Authors:  S Oguzhan; M Mese; M Schirren; M Baladov; J Schirren
Journal:  Chirurg       Date:  2019-12       Impact factor: 0.955

2.  Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review.

Authors:  Cristina Micali; Ylenia Russotto; Alessio Facciolà; Andrea Marino; Benedetto Maurizio Celesia; Eugenia Pistarà; Grazia Caci; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Emmanuele Venanzi Rullo
Journal:  Infect Dis Rep       Date:  2022-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.